Abbott Laboratories | 10-Q: Quarterly report
May 3 04:15
Abbott Laboratories | 8-K: Current report
May 2 04:07
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Stratton John G
May 1 06:32
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director STARKS DANIEL J
May 1 06:27
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Roman Michael F
May 1 06:22
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director O'Grady Michael
May 1 06:12
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director McKinstry Nancy
May 1 06:07
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director McDew Darren W
May 1 06:02
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Kumbier Michelle
May 1 05:57
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Gonzalez Patricia Paola
May 1 05:52
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Blount Sally E.
May 1 05:47
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Babineaux-Fontenot Claire
May 1 05:42
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J
May 1 05:36
Abbott Laboratories | 8-K: Current report
Apr 30 04:13
Abbott Laboratories | 8-K: Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
Apr 17 19:39
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Stratton John G
Apr 3 07:01
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Roman Michael F
Apr 3 06:55
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Gonzalez Patricia Paola
Apr 3 06:46
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J
Apr 3 06:37
Abbott Laboratories | DEF 14A: Definitive information statements
Mar 16 10:27
No Data
No Data